The Golden State Warriors have named Marty Glick as the team’s Chief Financial Officer (CFO), it was announced today. Glick, who is also a minority owner of the club, will begin his new duties immediately. He will oversee all day-to-day and long-term financial planning and accounting for the organization, while reporting directly to Co-Owner Joe Lacob.

Glick, a highly-regarded former biotech executive whose affiliations have a history of innovative success, has accumulated a wealth of experience as a prominent financial figure for several large biotech businesses, including Genentech of South San Francisco, where he spent over a decade (1987-1997), most recently as Vice President of Finance.

He also served as Executive Vice President and Chief Financial Officer of Theravance, a Bay Area-based drug discovery company, for seven years (1998-2005) and was a Co-Founder and Board Member of Eyetech Pharmaceuticals. Additionally, Glick was Co-Founder and Chairman of the Board of PEAK Surgical – an innovative private medical device company – and his resume also includes a seven-plus year stint as the Chair of the Biotech Tax and Finance Committee.